nodes	percent_of_prediction	percent_of_DWPC	metapath
Astemizole—CYP2J2—Cholecalciferol—psoriasis	0.403	0.417	CbGbCtD
Astemizole—CYP3A5—Beclomethasone—psoriasis	0.0637	0.0661	CbGbCtD
Astemizole—CYP2D6—Hydroxyurea—psoriasis	0.0296	0.0307	CbGbCtD
Astemizole—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0271	0.0281	CbGbCtD
Astemizole—CYP3A7—Hydrocortisone—psoriasis	0.0271	0.0281	CbGbCtD
Astemizole—CYP3A7—Cyclosporine—psoriasis	0.0256	0.0266	CbGbCtD
Astemizole—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0256	0.0266	CbGbCtD
Astemizole—CYP3A5—Mycophenolate mofetil—psoriasis	0.0254	0.0263	CbGbCtD
Astemizole—CYP3A4—Calcitriol—psoriasis	0.0221	0.023	CbGbCtD
Astemizole—CYP3A5—Hydrocortisone—psoriasis	0.0204	0.0211	CbGbCtD
Astemizole—CYP3A5—Cyclosporine—psoriasis	0.0192	0.0199	CbGbCtD
Astemizole—CYP2D6—Cholecalciferol—psoriasis	0.0179	0.0186	CbGbCtD
Astemizole—CYP3A4—Methoxsalen—psoriasis	0.0172	0.0179	CbGbCtD
Astemizole—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0169	0.0175	CbGbCtD
Astemizole—CYP3A7—Dexamethasone—psoriasis	0.0169	0.0175	CbGbCtD
Astemizole—ABCB1—Mycophenolate mofetil—psoriasis	0.0165	0.0171	CbGbCtD
Astemizole—ABCB1—Betamethasone—psoriasis	0.0142	0.0147	CbGbCtD
Astemizole—ABCB1—Prednisolone—psoriasis	0.014	0.0145	CbGbCtD
Astemizole—ABCB1—Hydrocortisone—psoriasis	0.0132	0.0137	CbGbCtD
Astemizole—ABCB1—Prednisone—psoriasis	0.0132	0.0137	CbGbCtD
Astemizole—CYP3A5—Dexamethasone—psoriasis	0.0127	0.0131	CbGbCtD
Astemizole—ABCB1—Cyclosporine—psoriasis	0.0125	0.013	CbGbCtD
Astemizole—CYP2D6—Cyclosporine—psoriasis	0.0118	0.0122	CbGbCtD
Astemizole—CYP3A4—Cholecalciferol—psoriasis	0.0114	0.0118	CbGbCtD
Astemizole—CYP3A4—Mycophenolate mofetil—psoriasis	0.00989	0.0103	CbGbCtD
Astemizole—CYP3A4—Triamcinolone—psoriasis	0.00989	0.0103	CbGbCtD
Astemizole—CYP3A4—Betamethasone—psoriasis	0.00849	0.0088	CbGbCtD
Astemizole—CYP3A4—Prednisolone—psoriasis	0.00837	0.00868	CbGbCtD
Astemizole—ABCB1—Dexamethasone—psoriasis	0.00824	0.00854	CbGbCtD
Astemizole—CYP3A4—Hydrocortisone—psoriasis	0.00794	0.00823	CbGbCtD
Astemizole—CYP3A4—Prednisone—psoriasis	0.00791	0.0082	CbGbCtD
Astemizole—CYP2D6—Dexamethasone—psoriasis	0.00776	0.00805	CbGbCtD
Astemizole—CYP3A4—Cyclosporine—psoriasis	0.0075	0.00777	CbGbCtD
Astemizole—ABCB1—Methotrexate—psoriasis	0.00662	0.00687	CbGbCtD
Astemizole—CYP3A4—Dexamethasone—psoriasis	0.00494	0.00512	CbGbCtD
Astemizole—CYP2J2—Xenobiotics—CYP2S1—psoriasis	0.00455	0.127	CbGpPWpGaD
Astemizole—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00189	0.0528	CbGpPWpGaD
Astemizole—CYP2J2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00186	0.0521	CbGpPWpGaD
Astemizole—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.00181	0.0507	CbGpPWpGaD
Astemizole—CYP2J2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00153	0.0428	CbGpPWpGaD
Astemizole—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.0015	0.0421	CbGpPWpGaD
Astemizole—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.0014	0.0392	CbGpPWpGaD
Astemizole—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.00131	0.0367	CbGpPWpGaD
Astemizole—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000931	0.0261	CbGpPWpGaD
Astemizole—CYP2J2—Biological oxidations—CYP2S1—psoriasis	0.000813	0.0227	CbGpPWpGaD
Astemizole—CYP2J2—Metapathway biotransformation—CYP2S1—psoriasis	0.000802	0.0224	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL22—psoriasis	0.000793	0.0222	CbGpPWpGaD
Astemizole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000753	0.0211	CbGpPWpGaD
Astemizole—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000743	0.0208	CbGpPWpGaD
Astemizole—CYP2J2—Tryptophan metabolism—CAT—psoriasis	0.000701	0.0196	CbGpPWpGaD
Astemizole—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00061	0.0171	CbGpPWpGaD
Astemizole—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000609	0.017	CbGpPWpGaD
Astemizole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000544	0.0152	CbGpPWpGaD
Astemizole—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000537	0.015	CbGpPWpGaD
Astemizole—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000441	0.0123	CbGpPWpGaD
Astemizole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000387	0.0108	CbGpPWpGaD
Astemizole—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000382	0.0107	CbGpPWpGaD
Astemizole—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000328	0.00919	CbGpPWpGaD
Astemizole—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.000324	0.00907	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000322	0.00901	CbGpPWpGaD
Astemizole—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.00032	0.00895	CbGpPWpGaD
Astemizole—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000314	0.00878	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—IL13—psoriasis	0.000254	0.00711	CbGpPWpGaD
Astemizole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000253	0.00708	CbGpPWpGaD
Astemizole—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00025	0.00699	CbGpPWpGaD
Astemizole—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000234	0.00656	CbGpPWpGaD
Astemizole—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000231	0.00647	CbGpPWpGaD
Astemizole—HRH1—IL-4 Signaling Pathway—SOCS1—psoriasis	0.000224	0.00627	CbGpPWpGaD
Astemizole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000205	0.00574	CbGpPWpGaD
Astemizole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000202	0.00566	CbGpPWpGaD
Astemizole—HRH1—IL-4 Signaling Pathway—IL4—psoriasis	0.000195	0.00547	CbGpPWpGaD
Astemizole—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000195	0.00545	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000192	0.00537	CbGpPWpGaD
Astemizole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000189	0.00528	CbGpPWpGaD
Astemizole—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000167	0.00466	CbGpPWpGaD
Astemizole—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000164	0.0046	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—NDUFA5—psoriasis	0.000163	0.00458	CbGpPWpGaD
Astemizole—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000162	0.00452	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—IL10—psoriasis	0.000159	0.00445	CbGpPWpGaD
Astemizole—HRH1—IL-4 Signaling Pathway—NFKBIA—psoriasis	0.000154	0.00431	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000152	0.00427	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.00015	0.00421	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL13—psoriasis	0.000149	0.00418	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—HCAR2—psoriasis	0.000146	0.00409	CbGpPWpGaD
Astemizole—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—psoriasis	0.000145	0.00406	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CYP2S1—psoriasis	0.000139	0.00389	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000137	0.00385	CbGpPWpGaD
Astemizole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000131	0.00368	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL12B—psoriasis	0.000128	0.00358	CbGpPWpGaD
Astemizole—HRH1—IL-4 Signaling Pathway—TYK2—psoriasis	0.000126	0.00353	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-E—psoriasis	0.000125	0.00349	CbGpPWpGaD
Astemizole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000116	0.00325	CbGpPWpGaD
Astemizole—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000109	0.00305	CbGpPWpGaD
Astemizole—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000107	0.00301	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000103	0.00289	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	9.97e-05	0.00279	CbGpPWpGaD
Astemizole—HRH1—IL-4 Signaling Pathway—NFKB1—psoriasis	9.83e-05	0.00275	CbGpPWpGaD
Astemizole—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	9.6e-05	0.00269	CbGpPWpGaD
Astemizole—CYP3A4—Tryptophan metabolism—CAT—psoriasis	9.4e-05	0.00263	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL10—psoriasis	9.34e-05	0.00262	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IL4—psoriasis	9.09e-05	0.00254	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-B—psoriasis	8.89e-05	0.00249	CbGpPWpGaD
Astemizole—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	8.88e-05	0.00248	CbGpPWpGaD
Astemizole—HRH1—IL-4 Signaling Pathway—STAT3—psoriasis	8.83e-05	0.00247	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—CXCL8—psoriasis	8.69e-05	0.00243	CbGpPWpGaD
Astemizole—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	8.27e-05	0.00232	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—HCAR2—psoriasis	8.26e-05	0.00231	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-A—psoriasis	8.23e-05	0.0023	CbGpPWpGaD
Astemizole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.1e-05	0.00227	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—JUN—psoriasis	8.08e-05	0.00226	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—NFKB1—psoriasis	7.78e-05	0.00218	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CCL20—psoriasis	7.6e-05	0.00213	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	7.52e-05	0.00211	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—HCAR2—psoriasis	7.5e-05	0.0021	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.28e-05	0.00204	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—VEGFA—psoriasis	7.06e-05	0.00198	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CARM1—psoriasis	6.79e-05	0.0019	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—NDUFA5—psoriasis	6.52e-05	0.00182	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.34e-05	0.00178	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—TNF—psoriasis	6.05e-05	0.00169	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CYP2S1—psoriasis	5.54e-05	0.00155	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—IFNG—psoriasis	5.49e-05	0.00154	CbGpPWpGaD
Astemizole—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	5.48e-05	0.00153	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—CXCL8—psoriasis	5.11e-05	0.00143	CbGpPWpGaD
Astemizole—KCNH2—SIDS Susceptibility Pathways—IL6—psoriasis	4.88e-05	0.00137	CbGpPWpGaD
Astemizole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	4.79e-05	0.00134	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—NDUFA5—psoriasis	4.71e-05	0.00132	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—HCAR2—psoriasis	4.43e-05	0.00124	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CCL20—psoriasis	4.29e-05	0.0012	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	4.21e-05	0.00118	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	4.18e-05	0.00117	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—CAT—psoriasis	4.17e-05	0.00117	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—VEGFA—psoriasis	4.15e-05	0.00116	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CYP2S1—psoriasis	4.01e-05	0.00112	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CCL20—psoriasis	3.9e-05	0.00109	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TAGAP—psoriasis	3.84e-05	0.00108	CbGpPWpGaD
Astemizole—ABCB1—Allograft Rejection—TNF—psoriasis	3.56e-05	0.000995	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—NDUFA5—psoriasis	3.56e-05	0.000995	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.54e-05	0.000989	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—NDUFA5—psoriasis	3.35e-05	0.000938	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	3.3e-05	0.000925	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—APOE—psoriasis	3.24e-05	0.000908	CbGpPWpGaD
Astemizole—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	3.15e-05	0.000882	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CYP2S1—psoriasis	3.02e-05	0.000846	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CYP2S1—psoriasis	2.85e-05	0.000797	CbGpPWpGaD
Astemizole—CYP2J2—Metabolism—PPARG—psoriasis	2.83e-05	0.000791	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CARM1—psoriasis	2.71e-05	0.000758	CbGpPWpGaD
Astemizole—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.69e-05	0.000754	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.34e-05	0.000656	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CCL20—psoriasis	2.3e-05	0.000645	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.26e-05	0.000631	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—NDUFA5—psoriasis	2.19e-05	0.000613	CbGpPWpGaD
Astemizole—HRH1—GPCR ligand binding—CXCL8—psoriasis	2.05e-05	0.000574	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.05e-05	0.000573	CbGpPWpGaD
Astemizole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.04e-05	0.000572	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CARM1—psoriasis	1.96e-05	0.000548	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CYP2S1—psoriasis	1.86e-05	0.000521	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.75e-05	0.000491	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—CAT—psoriasis	1.66e-05	0.000466	CbGpPWpGaD
Astemizole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.55e-05	0.000433	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CARM1—psoriasis	1.48e-05	0.000413	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CARM1—psoriasis	1.39e-05	0.000389	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—APOE—psoriasis	1.29e-05	0.000362	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—SOCS1—psoriasis	1.27e-05	0.000355	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—TYK2—psoriasis	1.21e-05	0.000338	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—CAT—psoriasis	1.2e-05	0.000337	CbGpPWpGaD
Astemizole—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.16e-05	0.000324	CbGpPWpGaD
Astemizole—CYP3A7—Metabolism—PPARG—psoriasis	1.13e-05	0.000315	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—CXCL8—psoriasis	1.05e-05	0.000295	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—LEP—psoriasis	9.36e-06	0.000262	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—APOE—psoriasis	9.36e-06	0.000262	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—APOE—psoriasis	9.35e-06	0.000262	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CARM1—psoriasis	9.09e-06	0.000255	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—CAT—psoriasis	9.08e-06	0.000254	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NFKBIA—psoriasis	8.72e-06	0.000244	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—CAT—psoriasis	8.56e-06	0.000239	CbGpPWpGaD
Astemizole—CYP3A5—Metabolism—PPARG—psoriasis	8.14e-06	0.000228	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TYK2—psoriasis	7.14e-06	0.0002	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—APOE—psoriasis	7.05e-06	0.000197	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—APOE—psoriasis	6.65e-06	0.000186	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—CXCL8—psoriasis	6.22e-06	0.000174	CbGpPWpGaD
Astemizole—ABCB1—Metabolism—PPARG—psoriasis	6.15e-06	0.000172	CbGpPWpGaD
Astemizole—HRH1—Signaling by GPCR—IL6—psoriasis	5.91e-06	0.000165	CbGpPWpGaD
Astemizole—CYP2D6—Metabolism—PPARG—psoriasis	5.79e-06	0.000162	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—JUN—psoriasis	5.78e-06	0.000162	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—CAT—psoriasis	5.59e-06	0.000157	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—NFKB1—psoriasis	5.56e-06	0.000156	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—VEGFA—psoriasis	5.05e-06	0.000141	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—STAT3—psoriasis	5e-06	0.00014	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—APOE—psoriasis	4.35e-06	0.000122	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—TP53—psoriasis	3.82e-06	0.000107	CbGpPWpGaD
Astemizole—CYP3A4—Metabolism—PPARG—psoriasis	3.79e-06	0.000106	CbGpPWpGaD
Astemizole—HRH1—Signaling Pathways—IL6—psoriasis	3.49e-06	9.78e-05	CbGpPWpGaD
